Skip to content

D&A at other companies

Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$463K-57.6%
Viatris logo
ViatrisVTRS
$676.1M+1.7%
PTH
Pelthos Therapeutics Inc.PTHS
$469K
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$597K-1.2%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$368K-77.7%
Opko Health logo
Opko HealthOPK
$22.2M-5.5%

Other financials

Income statement

See full
Revenue$8.6M+72.1%
Gross profit$4.2M+15.1%
Operating income-$32.2M-15.3%
Net income-$45.7M-75.0%
EPS (diluted)-$6.28-178%

Balance sheet

See full
Cash & equivalents$3.4M-42.2%
Total debt$95.4M+130%
Total equity-$249.2M-17.8%
Total assets$293.6M+272%

Cash flow

See full
Operating cash flow-$1.1M-118%
CapEx$33.3K
Free cash flow$920.8K-63.7%

Valuation

See full
Market cap$54.86M+88.7%
Enterprise value$146.86M+120%
P/S1.6×+1.0×

Profitability

See full
Gross margin59.7%-12.3pp
Operating margin-1,034.4%-1,313pp
Net margin-1,162.4%-1,359pp
FCF margin12.2%

Returns & leverage

See full
Return on equity170.9%
Debt / equity0.3×
Current ratio0.1×0.0×

Where this comes from

Reported directly by Scilex Holding Company in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Scilex Holding Company’s 10-Q, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scilex Holding Company's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scilex Holding Company's D&A?
Scilex Holding Company (SCLX) reported D&A of $2.87M in Q1 2026.
How has Scilex Holding Company's D&A changed year-over-year?
Scilex Holding Company's D&A increased by 186.0% year-over-year, from $1M to $2.87M.
What is the long-term trend for Scilex Holding Company's D&A?
Over 4 years (2021 to 2025), Scilex Holding Company's D&A has grown at a 5.2% compound annual growth rate (CAGR), from $3.78M to $4.62M.
What does D&A mean?
Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.